Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of Fluzone® (Influenza Vaccine) for the 2016-2017 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA) for shipment. This represents the first of more than 65 million total doses of seasonal influenza vaccine manufactured by Sanofi Pasteur that will be delivered to U.S. health care providers and pharmacies beginning in July and continuing throughout the remainder of the year. Sanofi Pasteur plans to increase its supply to respond to the shifting pediatric public health needs.
Seasonal influenza activity typically occurs between October and May and peaks between December and February. However, influenza activity peaked noticeably late last season occurring in early March 2016.1 Influenza seasons are always unpredictable as new influenza strains emerge and strain activity fluctuates throughout the year, making timely vaccination even more important to help protect against the virus, especially for seniors, young children and infants six months of age and older.
To view the multimedia release go to:
http://www.multivu.com/players/English/7842051-sanofi-pasteur-influenza-vaccine/
A new survey commissioned by Mucinex, the number one over-the-counter brand* in America, reveals that more than 158 million Americans (63 percent of the adult population) would try to hide being sick so they wouldn’t have FOMO (fear of missing out) on doing things they wanted to do. However, more than 206 million Americans (82 percent of those surveyed) would agree that when they see people out and about when they are sick, they wish those battling cold and flu symptoms stayed home instead. While this time of year is full of fun autumn activities and outings with family and friends, it’s also the beginning of cold and flu season, and the last thing people want to do is stay at home and battle a swarm of sick symptoms.
Influenza, flu, season is coming and you want to prepare yourself physically and mentally. Learn what you need to do so that you do not get the flu this year.
Crosstex International, a subsidiary of Cantel Medical Corp. (NYSE:CMN), and Prestige Ameritech, the only two major U.S.-based medical mask manufacturers have joined forces to bring attention to a glaring void in public health research and policy – that, if addressed, has the potential to more quickly provide a simple, effective tool to mitigate the spread of influenza and other respiratory borne viruses. The awareness campaign comes in response to a new study, “ Exposure to Influenza Virus Aerosols During Routine Patient Care,” published in The Journal of Infectious Diseases, showing that influenza viruses may spread as far as six feet from a person coughing or sneezing, and that some people, referred to as “super spreaders,” may be more likely to spread the virus. The study, supported by the Department of Health and Human Services with a $600,000 research grant, pointed specifically to concerns for healthcare workers being exposed to coughs from sick patients. Yet government research and policy continues to overlook face masks as a feasible protection measure for both the healthcare industry and the general public.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60417-cantel-medical-fitted-mask-infectious-disease-control-public-health-policy
A study published in the Journal of Infectious Diseases indicates that treatment with oseltamivir significantly reduces mortality in patients with influenza A/H5N1, or ‘bird flu,’ even when given late in the course of illness.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/outcome/46648/
For today’s busy families, getting sick is no fun. With cough, cold and flu season here, many parents are taking precautions to help keep their children healthy. According to the Centers for Disease Control and Prevention (CDC),¹ one of the best ways to protect against getting sick is to wash hands often. To help teach families about the importance of clean hands and preventing the spread of germs, Wet Ones® Antibacterial Hand Wipes has launched the Wet Ones Healthy Hands Zone™ website, an educational resource developed by Bill Nye, renowned science educator and author of Bill Nye the Science Guy's Great Big Book of Tiny Germs.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/playtex/47307/
In recognition of Family Vaccination Day today, Families Fighting Flu (FFF) encourages everyone to take an active role in keeping their family healthy this season by getting vaccinated against the flu. To educate the public about the importance of influenza vaccination, FFF is partnering with the Centers for Disease Control and Prevention (CDC) for the fourth year during National Influenza Vaccination Week (NIVW), December 5-11, 2010 – an observance established to highlight the importance of continuing influenza vaccination after the holiday season and into January and beyond.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/familiesfightflu/47482/
In recognition of Family Vaccination Day today, Families Fighting Flu (FFF) encourages everyone to take an active role in keeping their family healthy this season by getting vaccinated against the flu. To educate the public about the importance of influenza vaccination, FFF is partnering with the Centers for Disease Control and Prevention (CDC) for the fourth year during National Influenza Vaccination Week (NIVW), December 5-11, 2010 – an observance established to highlight the importance of continuing influenza vaccination after the holiday season and into January and beyond.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/familiesfightflu/47482/
As the season turns from fall to winter, many holiday displays replace pop-up flu vaccine clinics. Yet flu season is not over — it has barely begun. In the 35 years that the Centers for Disease Control and Prevention (CDC) has monitored influenza, February has been the most common month for peak flu activity, including during the 2010-2011 flu season. To share this important information and educate families around the country, Families Fighting Flu is joining the CDC once again during the annual National Influenza Vaccination Week (NIVW) — an observance to promote the importance of flu vaccination as the single best preventative measure against this disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52236-families-fighting-flu-psa-flu-survivor-luke-duvall-flu-prevention
Today, MedImmune Specialty Care division of AstraZeneca (MedImmune Specialty Care) announced it has joined with actress Tia Mowry to raise awareness about the importance of an annual flu vaccination. To kick-off the campaign, MedImmune Specialty Care and Mowry unveiled an online video, “I Insist!” (www.YouTube.com/InsistOnTheMist), which uses comedy to educate busy families about the importance of living a healthy lifestyle and making flu vaccination a priority. For Mowry, this includes vaccination with FluMistQuadrivalent, the first and only FDA-approved needle-free flu vaccine for eligible persons 2-49 years old. FluMist Quadrivalent is administered as a gentle mist sprayed into the nose, where the influenza virus usually enters the body.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63079-medimmune-specialty-care-tia-mowry-flumist-quadrivalent-encourage-flu-shot
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
